Loading organizations...
Loading organizations...
Biotech company developing targeted cancer therapies.
DeuterOncology has raised $6.1M across 1 funding round.
DeuterOncology has raised $6.1M in total across 1 funding round.
DeuterOncology has raised $6.1M in total across 1 funding round.
DeuterOncology's investors include InvestSud, Newton Biocapital, Noshaq.
DeuterOncology has raised $6.1M across 1 funding round. Most recently, it raised $6.1M Series A in January 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 19, 2023 | $6.1M Series A | InvestSud, Newton Biocapital, Noshaq |